Treatment of pulmonary fibrosis in one convalescent patient with corona virus disease 2019 by oral traditional Chinese medicine decoction: A case report / 中西医结合学报
Journal of Integrative Medicine
;
(12): 185-190, 2021.
Article
in English
| WPRIM
| ID: wpr-881006
ABSTRACT
After one-month of oral treatment with traditional Chinese medicine decoction, without using other drugs, the lung inflammatory exudate, pulmonary fibrosis and quality of life of a 61-year-old female patient with corona virus disease 2019 (COVID-19) were significantly improved. No recurrence or deterioration of the patient's condition was found within seven weeks of treatment and follow-up, and no adverse events occurred, indicating that oral Chinese medicine decoction was able to improve the pulmonary inflammation and fibrosis in a patient recovering from COVID-19, but further research is still needed.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Pulmonary Fibrosis
/
Drugs, Chinese Herbal
/
Administration, Oral
/
Magnoliopsida
/
Exudates and Transudates
/
SARS-CoV-2
/
COVID-19
/
Inflammation
/
Lung
/
Medicine, Chinese Traditional
Type of study:
Diagnostic study
Limits:
Female
/
Humans
Language:
English
Journal:
Journal of Integrative Medicine
Year:
2021
Type:
Article
Similar
MEDLINE
...
LILACS
LIS